Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
12/30/2004 | US20040267002 Use of novel virulence-specific genes as targets for diagnosis and potential control of virulent strains of listeria monocytogenes |
12/30/2004 | US20040266714 Modulate gene expression; diagnosis, therapy of disease; antidiabetic agents; insulin resistance |
12/30/2004 | US20040266713 Using nucleic acids; antitumor agents |
12/30/2004 | US20040266710 Immunotherapy; induce immunology response |
12/30/2004 | US20040266709 Immunotherapy; induction immunology response |
12/30/2004 | US20040266706 Cross-linked oligomeric compounds and their use in gene modulation |
12/30/2004 | US20040265999 Use of antisense oligonucleotides to inhibit the expression of human Akt-1 |
12/30/2004 | US20040265974 Human chemokine polypeptides |
12/30/2004 | US20040265972 Modified human chorionic gonadotropin (CG) for use in treatment and prevention of metabolic and reproductive diseases |
12/30/2004 | US20040265969 Reverse polymerases; kits; electrophoresis |
12/30/2004 | US20040265966 Secreted and transmebrane polypeptides and nucleic acids encoding the same |
12/30/2004 | US20040265963 Inhibitory peptide for use in treatment and prevention of nervous system, connective tissue, autoimmune, inflammatory and cell proliferative disorders |
12/30/2004 | US20040265955 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
12/30/2004 | US20040265954 Transgenic escherichia for use in the expression and propagation of N-glycosylated target proteins; bioreactors and heterologous protein expression |
12/30/2004 | US20040265885 Peptide nucleic acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone; can be purified using efficient methods such as chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
12/30/2004 | US20040265876 Isolated polynucleotide associated with Type II diabetes mellitus and methods of use thereof |
12/30/2004 | US20040265873 primer which specifically amplifies groEL2 gene; efficiently identify Streptomyces species; identifying a potato scab pathogenic microorganism using a new chronometer molecule as a target gene; groEL2 gene encodes a stress-related protein in bacteria whose function is well conserved |
12/30/2004 | US20040265870 amino-reactive nucleotides such as aminoallyl-dUTP or aminohexyl-dATP for synthesis |
12/30/2004 | US20040265867 the Riley-Day syndrome; localization will permit prenatal diagnosis in affected families |
12/30/2004 | US20040265866 Receptor on the surface of activated T-cells: ACT-4 |
12/30/2004 | US20040265858 Sets of generalized target-binding e-tag probes |
12/30/2004 | US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy |
12/30/2004 | US20040265852 Diangnosis and treatment of AUR1 and/or AUR2 related disorders |
12/30/2004 | US20040265849 Point mutation analysis of glyceraldehyde-3-phosphate dehydrogenase genes via allele-specific probe hybridization and/or nuclease digestion; kits; drug screening |
12/30/2004 | US20040265846 Screening point mutations to diagnose cardiovascular diseases, psychiatric diseases, or cancer; binding proteins; monoclonal antibodies; kits |
12/30/2004 | US20040265835 Fluorescence activated cell-sorting; liposomes; phospholipid mimics |
12/30/2004 | US20040265834 Antibodies; host cells; membrane proteins; for treatment of carcinoma, rheumatoid arthritis, asthma, kidney or testis related carcinoma, and neuron diseases |
12/30/2004 | US20040265833 Such as carcinomas, adenomas, and polyps; peptide nucleic acids; solid phase synthesis; microarrays; kits |
12/30/2004 | US20040265832 Genotyping short terminal repeats/markers; statistical analysis; drug screening |
12/30/2004 | US20040265802 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
12/30/2004 | US20040265796 Methods and kits for detecting SARS-associated coronavirus |
12/30/2004 | US20040265786 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments |
12/30/2004 | US20040265324 Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines |
12/29/2004 | WO2004113872A2 Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces |
12/29/2004 | WO2004113564A1 Method for investigating cytosine methylation in dna sequences by means of triplex-forming oligomers |
12/29/2004 | WO2004113554A2 Methods for determining susceptibility to psoriasis |
12/29/2004 | WO2004113553A2 Method of producing pure amidites and oligonucleotides |
12/29/2004 | WO2004113521A1 New biological entities and the use thereof |
12/29/2004 | WO2004113511A2 Cell line and uses thereof |
12/29/2004 | WO2004113501A2 Methods and compositions relating to lipid accumulation |
12/29/2004 | WO2004113500A2 B7s1: an immune modulator |
12/29/2004 | WO2004113497A2 Gene delivery to tumors |
12/29/2004 | WO2004113495A2 Rna-based transcriptional regulators |
12/29/2004 | WO2004113493A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
12/29/2004 | WO2004113361A2 Novel prokineticin receptor isoforms and methods of use |
12/29/2004 | WO2004112706A2 Vaccines, immunotherapeutics and methods for using the same |
12/29/2004 | WO2004112703A2 Interleukin-21 analogs |
12/29/2004 | WO2004112570A2 Detection of survivin in the biological fluids of cancer patients |
12/29/2004 | WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor |
12/29/2004 | WO2004093790A3 Yeast ectopically expressing abnormally processed proteins and uses therefor |
12/29/2004 | WO2004082640A3 Human serum albumin conjugates with therapeutic compounds |
12/29/2004 | WO2004074300A3 Novel photolabile protective groups for improved processes to prepare oligonucleotide arrays |
12/29/2004 | WO2004072244A3 Polymerase-based protocols for generating chimeric oligonucleotides |
12/29/2004 | WO2004053061A3 Methods of therapy and diagnosis using targeting of cells that express lax |
12/29/2004 | WO2004039309A3 Dc-sign isoforms, related compositions and methods for their use in disease therapy |
12/29/2004 | EP1491591A1 New fluorescence cyanine labels containing a sulfamido linker arm |
12/29/2004 | EP1491217A1 Stabilization of polynucleotide complexes |
12/29/2004 | EP1490515A1 Chloral-free dca in oligonucleotide synthesis |
12/29/2004 | EP1490511A2 Methods and systems for dynamic gene expression profiling |
12/29/2004 | EP1490490A2 Antisense iap nucleobase oligomers and uses thereof |
12/29/2004 | EP1490488A2 Purification methods for oligonucleotides and their analogs |
12/29/2004 | EP1490486A2 Method of identifying genes controlling diferentiation |
12/29/2004 | EP1490484A2 Further bmp-2 inducible kinases and the uses thereof |
12/29/2004 | EP1490385A2 Jagged 2 inhibitors for inducing apoptosis |
12/29/2004 | EP1490384A2 A building block forming a c-c bond upon reaction |
12/29/2004 | EP1379140A4 Production of pancreatic islet cells and delivery of insulin |
12/29/2004 | EP1117808B1 Transformation system in the field of filamentous fungal hosts: in chrysosporium |
12/29/2004 | EP0898575B1 A combinatorial protecting group strategy for multifunctional molecules |
12/29/2004 | EP0785946B1 Materials for the production of nanometer structures and use thereof |
12/29/2004 | EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS |
12/29/2004 | EP0653940B1 Glial mitogenic factors, their preparation and use |
12/29/2004 | CN1558914A Receptor, the use thereof, and mouse antibodies |
12/29/2004 | CN1558207A Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
12/29/2004 | CN1557827A Gene associated with schizophrenia and polymorphism site and use thereof |
12/29/2004 | CN1182252C Prepn. of double-stranded nucleic acid on surface of solid support |
12/29/2004 | CA2529882A1 Cell line and uses thereof |
12/29/2004 | CA2529659A1 Engineered proteolytic enzyme with altered specificity determining regions |
12/29/2004 | CA2529639A1 Detection of survivin in the biological fluids of cancer patients |
12/29/2004 | CA2529520A1 Interleukin-21 analogs |
12/29/2004 | CA2529051A1 Vaccines, immunotherapeutics and methods for using the same |
12/29/2004 | CA2526648A1 Method for producing a synthetic gene or other dna sequence |
12/29/2004 | CA2525379A1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
12/28/2004 | US6835827 Labelled oligonucleotides synthesized on solid-supports |
12/28/2004 | US6835826 Acid resistance, stability; telomerase inhibitor |
12/28/2004 | US6835825 For regulating activation/development/differentiation of hematopoietic cells |
12/23/2004 | WO2004111220A1 Proteases |
12/23/2004 | WO2004111217A2 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products |
12/23/2004 | WO2004111200A2 Rtvp-glipr-like compositions and methods for the detection, treatment and prevention of prostate cancer |
12/23/2004 | WO2004111191A2 Methods and compositions for controlling efficacy of rna silencing |
12/23/2004 | WO2004111190A2 IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES |
12/23/2004 | WO2004111075A2 Alternative reading frame polypeptides for treatment |
12/23/2004 | WO2004111074A2 In vivo production of a clostridial neurotoxin light chain peptide |
12/23/2004 | WO2004111072A2 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same |
12/23/2004 | WO2004110371A2 Method for the treatment of malignancies |
12/23/2004 | WO2004110367A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
12/23/2004 | WO2004110345A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
12/23/2004 | WO2004110246A2 Methods and compositions for diagnosing conditions associated with specific dna methylation patterns |
12/23/2004 | WO2004097039A9 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue |
12/23/2004 | WO2004083386A3 Methods of making repetitive sequences removed probes and use thereof |
12/23/2004 | WO2004074439A9 An expression cassette and vector for transient or stable expression of exogenous molecules |